MetaCap

Latigo Biotherapeutics Statistics

NASDAQ: LTGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.00-0.24 (-1.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Latigo Biotherapeutics by the numbers

Latigo Biotherapeutics has a market capitalization of $861.9 million based on 66.30M shares outstanding. With trailing EPS of $-6.07, Latigo Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.1% below its 50-day average and 27.3% below its 200-day average.

Average daily trading volume is 309.60K shares, or about $4.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LTGO valuation vs. peer median

LTGO compared with the median of 8 peer companies
MetricLTGOPeer medianDifference
Market cap$861.89M$879.04M-2%
Avg. volume309.60K945.31K-67%

Peer median across 8 companies: MTRI, AKTS, PHAR, SVRA, CRVS, MLTX, VSTM, CYRX.

Valuation

Price and trading

Previous close
13.24
Open
13.22
Day range
11.91 – 13.35
52-week range
10.24 – 25.93
Beta
—
Volume
267.17K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
861.89M
Forward Pe
-6.22
Eps
-6.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
25.93
Week52 Low
10.24
Avg Volume
309.60K
Shares Outstanding
66.30M
Ma50
16.07
Ma200
17.89
Earnings Date
Dec 3, 2026
Pct From52w High
-49.87%
Pct From52w Low
26.95%

Related